Allergan’s Peculiar Non-GAAP Reporting, Wendy’s Free Cash Flow, More Reports
In alphabetical order by ticker symbol: AGN, EA, ENR, LYFT MYL, PZZA, S, WEN. — Allergan (AGN): Allergan’s first-quarter report, released May 7, came in better than expected, despite the headline numbers not looking that great. GAAP net revenue declined 2% on a year-over-year basis, while it posted a rather large operating loss. The Botox maker continues to advance its pipeline, and it raised its non-GAAP top and bottom-line guidance for fiscal 2019. However, we can’t get comfortable with the huge discrepancy between GAAP and non-GAAP bottom-line guidance. The former calls for a loss of $5.70 per share on the year, while the latter calls for a gain of $16.55 per share on the year. What’s worse, the GAAP bottom-line earnings guidance … Read more